Relationship between Methylation Status of Multi-drug Resistance Protein (MRP) and Multi-drug Resistance in Lung Cancer Cell Lines

被引:0
|
作者
Li, Hong [2 ]
Zhu, Yi-Fei [1 ]
Zheng, Shi-Ying [1 ]
Jiang, Dong [1 ]
机构
[1] Suzhou Univ, Affiliated Hosp 1, Dept Cardiothorac Surg, Suzhou 215006, Jiangsu Prov, Peoples R China
[2] Suzhou Univ, Affiliated Hosp 1, Dept Geriatr, Suzhou 215006, Jiangsu Prov, Peoples R China
关键词
Lung cancer; Multi-drug resistance protein(MRP); Methylation Multi-drug resistance(MDR); CPG HYPERMETHYLATION; PROSTATE-CANCER; PROMOTER REGION; GENE; ALPHA;
D O I
10.1109/FBIE.2009.5405779
中图分类号
R318 [生物医学工程];
学科分类号
0831 ;
摘要
Objective: To study the relationship between the methylation status of multi-drug resistance protein (MRP) gene and the expression of its mRNA and protein in lung cancer cell lines. Methods:Human lung cell line WI-38.lung adenocarcinoma cell line SPCA-1 and its drug-resistant cells induced by different concentrations of doxorubicin were treated with restriction endonuclease Eco47III.The methylation status of MRP was examined by PCR,and the expressions of its mRNA and protein were evaluated by in situ hybridization and immunohistochemistry. Resuits: MRP gene promoter region of WI-38 cells was in hypermethylation status.but the promoter region of MRP in SPCA-1 cells and their resistant derivatives induced by different concentrations of doxorubicin were in hypomethylation status.There were Significant differences in the expression of MRP mRNA among WI-38 cell line.SPCA-1 cells and their drug-resistan t derivatives induced by different con- centration of doxorubicin.Consistently.MRP immunostaining presented similar significant differences. Conclusion:The promoter region of MRP in SPCA-1 lung adenocarcinoma cells was in hypomethylation status. The hypomethylation status of regulatory region of MRP promoter is an important structural basis that can increase the activity of transcrip-tion and results in the development of drug resistan cc in lung cancer.
引用
收藏
页码:548 / +
页数:2
相关论文
共 50 条
  • [21] Detection and characterisation of multi-drug resistance protein 1 (MRP-1) in human mitochondria
    E A Roundhill
    S A Burchill
    British Journal of Cancer, 2012, 106 : 1224 - 1233
  • [22] Detection and characterisation of multi-drug resistance protein 1 (MRP-1) in human mitochondria
    Roundhill, E. A.
    Burchill, S. A.
    BRITISH JOURNAL OF CANCER, 2012, 106 (06) : 1224 - 1233
  • [23] Outsmarting multi-drug resistance in uncertain times
    不详
    JAC-ANTIMICROBIAL RESISTANCE, 2020, 2 (04):
  • [24] Polyene multi-drug resistance reversal agents
    Andrus, MB
    CURRENT OPINION IN DRUG DISCOVERY & DEVELOPMENT, 2004, 7 (06) : 823 - 831
  • [25] Strategies to Combat Multi-Drug Resistance in Tuberculosis
    Singh, Vinayak
    Chibale, Kelly
    ACCOUNTS OF CHEMICAL RESEARCH, 2021, 54 (10) : 2361 - 2376
  • [26] Multi-drug resistance in chronic lymphocytic leukemia
    Friedenberg, WR
    Spencer, SK
    Musser, C
    Hogan, TF
    Rodvold, KA
    Rushing, DA
    Mazza, JJ
    Tewksbury, DA
    Marx, JJ
    LEUKEMIA & LYMPHOMA, 1999, 34 (1-2) : 171 - 178
  • [27] Is Glycyrrhizin the Magic Bullet for Multi-drug Resistance?
    Hazlett, Linda D.
    Ekanayaka, Sandamali Amarasingha
    McClellan, Sharon A.
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2019, 60 (09)
  • [28] Paraoxonase 3 is involved in the multi-drug resistance of esophageal cancer
    Dabing Huang
    Yong Wang
    Yifu He
    Gang Wang
    Wei Wang
    Xinghua Han
    Yubei Sun
    Lin Lin
    Benjie Shan
    Guodong Shen
    Min Cheng
    Geng Bian
    Xiang Fang
    Shilian Hu
    Yueyin Pan
    Cancer Cell International, 18
  • [29] Regulation of multi-drug resistance in Erwinia chrysanthemi
    Ravirala, R.
    Francisco, M. San
    Lee, C.
    PHYTOPATHOLOGY, 2005, 95 (06) : S86 - S86
  • [30] Recent strategies for the treatment of multi-drug resistance in cancer cells
    Ojima, I
    Bounaud, PY
    Oderda, CF
    EXPERT OPINION ON THERAPEUTIC PATENTS, 1998, 8 (12) : 1587 - 1598